|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 1/1/2024 |
||||
| 2. House Identification | 565120001 |
Senate Identification | 401108536-60141 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | MEDSECUREAN.COM |
||||
| Address | 74 Windy Hollow Court |
Address2 |
|
| City | Great Falls |
State | VA |
Zip | 22066 |
Country | USA |
4. Principal place of business (if different than line 3)
| City |
|
State |
|
Zip |
|
Country |
|
| 5. Contact name and telephone number | International Number |
| Contact | Ms. Kathleen Jaeger |
Telephone | 7034248049 |
kjaeger@medsecurean.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Indian Pharmaceutical Alliance (formerly Indian Pharmaceutical Association) |
| Address | A-205, Sangam Building 14B |
| City | Mumbai |
State |
|
Zip | 4000 054 |
Country | IND |
| City |
|
State |
|
Zip |
|
Country |
|
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| Kathleen | Jaeger | | |
| | | | |
| | | | |
| | | | |
| | | | |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
HCR |
TRD |
|
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
IPA is dedicated to advancing and resolving critical issues that impact the generic medicine sector with a focus on the primary three areas: Healthcare Policy: IPA actively works to influence health policy reforms that promote access to affordable medicines and support public health goals. This includes advocating for policies that ensure patient access to affordable medications through necessary reforms of the Hatch-Waxman Act: mantaining a balance between fostering brand innovation and timely entry of generics. Also, IPA actively seeks to establish a U.S.-India partnership focused on affordable medicine,partnership aims to enhance supply chain resiliency and national security.
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: |
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
|
|
|||||||||||
|
|
|
|
|
% | |||||||
|
|
|||||||||||
|
|
|
|
|
% |
CONVICTIONS DISCLOSURE
15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Signature | Digitally Signed By: Kathleen D Jaeger |
Date | 3/5/2025 1:14:38 PM |